The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancer.
作者信息
Komuta Mina, Ueno Akihisa, Sakamoto Michiie
机构信息
Department of Pathology, International University of Health and Welfare, School of Medicine , Narita Hospital , Chiba , Japan.
Department of Pathology , Keio University School of Medicine , Tokyo , Japan.
出版信息
Hepatology. 2023 Jan 1;77(1):10-12. doi: 10.1002/hep.32452. Epub 2022 Mar 28.
PMID:35263454
Abstract
摘要
相似文献
1
The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancer.
Hepatology. 2023 Jan 1;77(1):10-12. doi: 10.1002/hep.32452. Epub 2022 Mar 28.
2
[Updated standards for the diagnosis and treatment of primary liver cancer].
Zhonghua Gan Zang Bing Za Zhi. 2012 Jun;20(6):419-26.
3
[Progress in diagnosis and treatment of primary liver cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):363-5.
4
[Improvement in diagnosis and treatment of primary liver cancer. An analysis of 1,045 cases].
Zhonghua Zhong Liu Za Zhi. 1982 Nov;4(4):279-82.
5
Clinical advances in primary liver cancer in China.
Hepatogastroenterology. 2001 Jan-Feb;48(37):29-32.
6
[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].
Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112-128. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004.
7
Immunotargeting in the diagnosis and treatment of liver cancer.
Hepatology. 1989 Apr;9(4):646-8. doi: 10.1002/hep.1840090421.
8
Early detection of liver cancer: diagnosis and management.
Curr Gastroenterol Rep. 2008 Feb;10(1):60-6. doi: 10.1007/s11894-008-0010-2.
9
[Diagnosis and treatment of hepatic cancer].
Nihon Naika Gakkai Zasshi. 1998 Sep 10;87(9):1848-55. doi: 10.2169/naika.87.1848.
10
[Nursing process: nursing of patients with liver cancer. Diagnosis and treatment of liver cancer].
Kurinikaru Sutadi. 1983 Feb;4(2):145-53.
引用本文的文献
1
The Impact of Normal Hepatobiliary Cell Zonation Programs on the Phenotypes and Functions of Primary Liver Tumors.
Liver Cancer. 2024 Aug 26;14(1):92-103. doi: 10.1159/000541077. eCollection 2025 Mar.
2
SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis.
Apoptosis. 2024 Oct;29(9-10):1723-1737. doi: 10.1007/s10495-024-02009-5. Epub 2024 Aug 2.
3
Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist.
J Liver Cancer. 2024 Mar;24(1):17-22. doi: 10.17998/jlc.2023.12.11. Epub 2024 Jan 3.
4
Integration analysis of miRNA-mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma.
Sci Rep. 2023 May 24;13(1):8362. doi: 10.1038/s41598-023-35288-0.
Zotero 插件